Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Research and standardization in Alzheimer's trials: Reaching international consensus

Carrillo, M.C., Rowe, C.C., Szoeke, C., Masters, C.L., Ames, D., O'Meara, T., Macaulay, S.L., Milner, A., Ellis, K.A., Maruff, P., Rainey-Smith, S.R., Martins, R.N., Bain, L.J. and Head, R.J. (2012) Research and standardization in Alzheimer's trials: Reaching international consensus. Alzheimer's & Dementi, 9 (2). pp. 160-168.

Link to Published Version:
*Subscription may be required


Alzheimer's disease (AD) is an epidemic facing the entire world. Increased knowledge gained during the past 25 years indicates that AD falls along a clinical and neuropathological spectrum represented as a continuum that extends from preclinical disease in which there are no symptoms, through early symptomatic phases, and finally to AD dementia. The Alzheimer's research community recognizes that imaging, body fluids, and cognitive biomarkers contribute to enhanced diagnostic confidence for AD. There has also been emerging consensus regarding the use of AD biomarkers in clinical trials. The use of biomarkers in clinical trials and practice is hampered by the lack of standardization. In response to the emerging need for standardization, an international meeting of AD researchers was held in Melbourne, Australia, in March 2012 to bring together key researchers, clinicians, industry, and regulatory stakeholders with the aim of generating consensus on standardization and validation of cognitive, imaging, and fluid biomarkers, as well as lifestyle parameters used in research centers worldwide.

Item Type: Journal Article
Publisher: Wiley
Copyright: © 2013 The Alzheimer's Association
Item Control Page Item Control Page